The European EGPA Study Group (EESG) was established in 2018 by Giacomo Emmi (Cattinara University Hospital, Trieste, Italy), Benjamin Terrier (Cochin University Hospital, Paris, France), and Augusto Vaglio (IRCCS Meyer University Hospital, Firenze, Italy) with the intention to create a network of scientists and clinicians from European Eosinophilic Granulomatosis with Polyangitiis (EGPA) referral centers, gathering clinical and scientific excellence and expertise to:
The EESG currently consists of over 100 centers across Europe and actively cooperates with patient advocacy organizations (PAOs), as well as other scientific societies and groups working in the field of vasculitis.
To strengthen this network, EESG meetings are organized every year to discuss and share ideas and brought up new research proposals and projects. Since its inception, several studies have been conducted on clinical and therapeutic aspects of the disease, while a tight collaboration with PAOs has been also consolidated, emphasising the priority mission of building patient’s empowerment, reinforcing the therapeutic alliance between patients and physicians, and creating opportunities for cohesion and education.
FOR ADDITIONAL INFORMATIONS REGARDING EESG RESEARCH ACTIVITY, PLEASE VISIT
in preparation
in preparation
Vasculitis & Lupus Research Group
Department of Medicine
Level 5, Box 157
Addenbrookes Hospital
Cambridge CB2 0QQ
United Kingdom
T: +44 (0)1223 748062
E: ke295@cam.ac.uk